Health Highlights: Oct. 1, 2021
Merck to seek emergency approval for its new COVID antiviral pill: In a trial of the drug molnupiravir, the risk of hospitalization and death was halved when given to high-risk patients within five days of infection. Read more Has the pandemic made the opioid epidemic worse? In interviews with HealthDayContinue Reading










